Notable Analyst Rating Changes 3/14: BA, XOM, EK Upgraded; WLP, BBD, TEVA Downgraded
More News related to BA
- Boeing (BA) Lost Orders For 15 787 Dreamliners In Past Week - Bloomberg
- Boeing Company (BA) Announces Q2 Deliveries
- Boeing Reports Second-Quarter Deliveries
- flydubai Signs Finance Deal for Four Boeing B737-800 (BA) aircraft with GE Capital Aviation Services (GE)
- ATK Awarded Contract for Ares I Upper Stage Ullage Motor
More News related to BBD
- Webcast Alert: Banco Bradesco S/A Announces Conference Call Webcast
- Webcast Alert: Banco Bradesco S/A Announces Conference Call Webcast
- Notable Analyst Rating Changes 3/9: KO, AMZN, BBY, GENZ Upgraded; PBR, BBD, AFL Downgraded
- Goldman Sachs Downgrades Banco Bradesco SA (BBD) to Sell
- Notable Analyst Rating Changes 3/3: DWA, BBD, ARO Upgraded; UBS, CS, DHI, CTX, GENZ Downgraded
More News related to EK
- Eastman Kodak (EK) Adds Joel Seligman to Board of Directors
- Kodak Board Elects Joel Seligman to Board of Directors
- Kodak Identifies Yellow Rose Boy with Help of Online Communities
- Americans Are Lonelier Than Ever Despite Being Increasingly Connected by Technology; Pictures Can Help
- Kodak Offers Reward to Help Connect Actress Megan Fox and 'Boy with Yellow Rose'
StreetInsider.com Notable Analyst Rating Changes:
UPGRADES:
Morgan Stanley upgrades Boeing (NYSE: BA) from Equalweight to Overweight.
Credit Suisse upgrades Exxon Mobil (NYSE: XOM) from Neutral to Outperform. Price target $102.
Citi upgrades Eastman Kodak Co (NYSE: EK) from Sell to Hold. Price target $20.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
BofA downgrades WellPoint (NYSE: WLP) from Buy to Neutral.
Goldman Sachs downgrades Banco Bradesco S.A. (NYSE: BBD) from Buy to Neutral.
Citi downgrades Teva Pharmaceutical (Nasdaq: TEVA) from Buy to Hold. Price target $50.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
J.P. Morgan initiates coverage on Southern Copper Corp. (NYSE: PCU) with an Underweight.
ThinkEquity initiates coverage on Intuitive Surgical (Nasdaq: ISRG) with a Buy. Price target $360.
Credit Suisse initiates coverage on Rayonier (NYSE: RYN) with an Outperform.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
-14.74
+12.57Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
